News Releases

Submissions & Studies

August 12, 2009 Comprehensive Study The Real Story Behind R&D Spending by Brand-Name Drug Companies in Canada
December 1, 2008 Comprehensive Study Response to the Fraser Institute's Report - Canada's Drug Price Paradox 2008
September 17, 2008 Submission to the Government of Canada Anti-Counterfeiting Trade Agreement
July 2008 Comprehensive Study The Real Story Behind Big Pharma’s R&D Spending in Canada
May 13, 2008 Submission to the Standing Committee on Health Review of the 10-Year Plan to Strengthen Health Care
April 16, 2008 Submission to the Standing Committee on Industry, Science and Technology Study on Science and Technology
September 2007 Comprehensive Study The Real Story Behind Big Pharma’s R&D Spending in Canada
Novemember 2005 Comprehensive Study Comparisons of Retail Prices of Generic Prescription Drugs in Canada vs. United States
December 2004 Comprehensive Study Patently Absurd: Evergreening of Pharmaceutical Patents under the Patented Medicines (Notice of Compliance) Regulations of Canada’s Patent Act
February 2004 Submission to House of Commons Standing Committee on Industry, Science and Technology Bill C-9, An Act to amend the Patent Act and the Food and Drugs Act
February 2004 Submission to Quebec’s Standing Committee on Finance and Economic Affairs Three Proposals for $70 Million in Annual Health Care Savings
November 2003 Submission to House of Commons Standing Committee on Health Generic Drug Makers at a Crossroads: The Path to Health-Care Savings and the Sustainability of Canada’s Generic Pharmaceutical Industry
June 2003 Submission to House of Commons Standing Committee on Industry, Science and Technology Patented Medicines (Notice of Compliance) Regulations
		TOP